Galectin-2, aa1-132, Recombinant, Human (Galectin2, LGALS2, Gal-2, Beta-galactoside-binding Lectin L-14-II, HL14, Lactose-binding Lectin 2, S-Lac Lectin 2)
Catalog No : USB-G1044-49
508.06€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Galectin-2, aa1-132, Recombinant, Human (Galectin2, LGALS2, Gal-2, Beta-galactoside-binding Lectin L-14-II, HL14, Lactose-binding Lectin 2, S-Lac Lectin 2) | ||
|---|---|---|---|
| Catalog No | USB-G1044-49 | ||
| Supplier’s Catalog No | G1044-49 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E.coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 16.8 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE). | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 0.2M sodium chloride, 1mM DTT, 10% glycerol. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE). | ||
| Description | LGALS2, also known as galectin2, is a soluble beta-galactoside binding lectin that modulates cell-to-cell adhesion and cell-to-extracellular matrix interactions and play a role in tumor progression, pre-mRNA splicing and apoptosis. This protein induces apoptosis in activated T cells and binds to the cytokine lymphotoxin-alpha (LTA) with possible implications in risk of myocardial infarction. Source: Recombinant corresponding to aa1-132 of human recombinant LAGALS2 fused to His-tag at N-terminus, expressed in E.coli. AA Sequence: MGSSHHHHHH SSGLVPRGSH MTGELEVKNM DMKPGSTLKI TGSIADGTDG FVINLGQGTD KLNLHFNPRF SESTIVCNSL DGSNWGQEQR EDHLCFSPGS EVKFTVTFES DKFKVKLPDG HELTFPNRLG HSHLSYLSVR GGFNMSSFKL KE Molecular Weight: 16.8kD (152aa), confirmed by MALDI-TOF Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing.. Store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved